Two Sigma Investments
MGX icon

Two Sigma Investments’s Metagenomi Therapeutics MGX Stock Holding History

Two Sigma Investments’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$666K Buy
496,767
+55,379
+13% +$86K ﹤0.01% 3533
2025
Q4 		$715K Buy
441,388
+233,860
+113% +$506K ﹤0.01% 3124
2025
Q3 		$492K Buy
207,528
+193,641
+1,394% +$393K ﹤0.01% 2994
2025
Q2 		$20.6K Sell
13,887
-44,461
-76% -$69.6K ﹤0.01% 3117
2025
Q1 		$79.4K Buy
58,348
+31,877
+120% +$76K ﹤0.01% 2991
2024
Q4 		$95.6K Sell
26,471
-59,135
-69% -$143K ﹤0.01% 2974
2024
Q3 		$186K Buy
85,606
+47,912
+127% +$166K ﹤0.01% 2811
2024
Q2 		$154K Buy
37,694
+17,535
+87% +$120K ﹤0.01% 2776
2024
Q1 		$213K Buy
+20,159
New +$232K ﹤0.01% 2691

Other funds holding MGX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments's MGX Position: Q1 2026 in Review

Two Sigma Investments increased its Metagenomi Therapeutics (MGX) stake by 13% in Q1 2026, buying an estimated $86K and bringing the position to 496,767 shares worth $666K. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

Two Sigma Investments first reported a position in MGX in Q1 2024 and has held it in 9 quarters since. The position peaked at $715K in Q4 2025. 48 funds tracked by Wall St. Rank hold MGX as of Q1 2026.

  • Two Sigma Investments held 496,767 shares of Metagenomi Therapeutics worth $666K as of Q1 2026.
  • Two Sigma Investments bought 55,379 Metagenomi Therapeutics shares in Q1 2026, an estimated $86K.
  • Metagenomi Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3533 holding.
  • Two Sigma Investments first reported a position in Metagenomi Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Two Sigma Investments's Metagenomi Therapeutics position peaked at $715K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.